03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock.
sec.report/Document/0001104659-20-029961/a20-11569_2sc13g.htm
To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:
In the Coronavirus Market:
COCP is to Treatment what 
IBIO is to Vaccines or what 
OPK is to Testing.
COCP has completed all the financing and funding needed with two public offerings recently and are now aggressively pursing the development of Novel Anitiviral Compounds for treatment of any Corona infections including COVID-19
They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.
Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position
sec.report/Document/0001104659-20-029961/a20-11569_2sc13g.htm
To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:
In the Coronavirus Market:
COCP is to Treatment what IBIO is to Vaccines or what OPK is to Testing.COCP has completed all the financing and funding needed with two public offerings recently and are now aggressively pursing the development of Novel Anitiviral Compounds for treatment of any Corona infections including COVID-19They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.
Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。